Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.

Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.

As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.

How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.

Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.